reports
- ABGSC Strategy Research
- Christer Linde
Mawson Infrastructure Group Announces Hiring of Head of Corporate Stra...
Mawson Infrastructure Group Announces Hiring of Head of Corporate Strategy and Head of Corporate Development New Hires Enhance Mawson’s Continued Transformation, Growth Initiatives and Ecosystem Consolidation Opportunities MIDLAND, Pa., May 09, 2024 (GLOBE NEWSWIRE) -- Mawson Infrastructure Group Inc. (NASDAQ: MIGI) (“Mawson,” or “the Company”), a digital infrastructure company, today announced that it has named Anurag Gandhi as Head of Corporate Strategy, and Vikram Murali as Head of Corporate Development, to enhance Mawson’s continued focus and transformation, strategic growth initiat...
Runway Growth Finance Corp. Announces Secondary Offering of Common St...
Runway Growth Finance Corp. Announces Secondary Offering of Common Stock by Selling Stockholder MENLO PARK, Calif., May 09, 2024 (GLOBE NEWSWIRE) -- Runway Growth Finance Corp. (Nasdaq: RWAY) (the “Company” or “Runway Growth”) a specialty finance company focused on providing senior secured loans to high growth-potential companies in technology, life sciences, healthcare information and services, business services, select consumer services and products and other high-growth industries, today announced a proposed underwritten secondary offering of 3,750,000 shares of its common stock by OC...
Silver Spike Investment Corp. Reports First Quarter 2024 Financial Res...
Silver Spike Investment Corp. Reports First Quarter 2024 Financial Results and Announces Cash Dividend of $0.25 Per Share NEW YORK, May 09, 2024 (GLOBE NEWSWIRE) -- Silver Spike Investment Corp. (“SSIC” or the “Company”) (NASDAQ: SSIC), a specialty finance company that has elected to be regulated as a business development company, today announced its financial results for the first quarter ended March 31, 2024. Quarter Ended 3/31/24 Highlights Total investment income of $2.8 millionNet investment income (loss) of $(0.1) million, or $(0.01) per shareInvestment portfolio of $54.8 million ...
Orezone Announces Planned Board Succession and New Board Nominee
Orezone Announces Planned Board Succession and New Board Nominee VANCOUVER, British Columbia, May 09, 2024 (GLOBE NEWSWIRE) -- Orezone Gold Corporation (TSX: ORE, OTCQX: ORZCF) (“Orezone” or the “Company”) announces the upcoming retirement of Michael Halvorson and Charles Oliver as part of the Company’s board succession plan and welcomes Tara Hassan as a new board nominee. Board Succession Mr. Halvorson, who has been a director of the Company since 2009 and Chair of the board since 2018, has announced to the Company that he will retire from the Chair position and not stand for re-electi...
Alaris Equity Partners Income Trust Releases 2024 First Quarter Financ...
Alaris Equity Partners Income Trust Releases 2024 First Quarter Financial Results NOT FOR DISTRIBUTION IN THE UNITED STATES.FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAW. CALGARY, Alberta, May 09, 2024 (GLOBE NEWSWIRE) -- Alaris Equity Partners Income Trust (together, as applicable, with its subsidiaries, “Alaris” or the "Trust") is pleased to announce its results for the three months ended March 31, 2024. The results are prepared in accordance with IFRS Accounting Standards as issued by the International Accounting Standards Board. A...
Travere Therapeutics to Present at National Kidney Foundation Spring C...
Travere Therapeutics to Present at National Kidney Foundation Spring Clinical Meetings and the 61st European Renal Association Congress Presentations highlight data supporting FILSPARI® (sparsentan) as a foundational therapy over historical RASi standard of care and in newly diagnosed patients with IgAN SAN DIEGO, May 09, 2024 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc., (Nasdaq: TVTX) today announced that the Company will present nine abstracts in rare kidney disease at the National Kidney Foundation (NKF) Spring Clinical Meetings in Long Beach, California, May 14-18, 2024, and the E...
Mercer International Inc. Reports First Quarter 2024 Results and Annou...
Mercer International Inc. Reports First Quarter 2024 Results and Announces Quarterly Cash Dividend Of $0.075 Selected Highlights First quarter Operating EBITDA* of $63.6 million and net loss of $16.7 million Improving pulp markets and lower costs driving stronger EBITDA Quarterly cash dividend of $0.075 per share NEW YORK, May 09, 2024 (GLOBE NEWSWIRE) -- Mercer International Inc. (Nasdaq: MERC) today reported first quarter 2024 Operating EBITDA of $63.6 million, an increase from $27.5 million in the same quarter of 2023 and $21.1 million in the fourth quarter of 2023....
Theratechnologies Reports on its Annual Meeting of Shareholders
Theratechnologies Reports on its Annual Meeting of Shareholders MONTREAL, May 09, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, reported the voting results from its annual meeting of shareholders held today in a virtual-only setting. Shareholders proceeded to elect the below candidates to the Company’s Board of Directors for a one-year term and appointed KPMG LLP as the Company’s auditors for the current fiscal year. All ...
Theratechnologies rend compte de son assemblée annuelle des actionnair...
Theratechnologies rend compte de son assemblée annuelle des actionnaires MONTRÉAL, 09 mai 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (« Theratechnologies » ou la « Société ») (TSX : TH) (NASDAQ : THTX), une société biopharmaceutique axée sur le développement et la commercialisation de traitements innovateurs, a rapporté les résultats du vote lors de son assemblée annuelle des actionnaires qui a eu lieu aujourd’hui en mode virtuel uniquement. Les actionnaires ont voté pour les divers candidats mentionnés ci-dessous en vue de leur élection au conseil d’administration de la S...
U.S. Energy Corp. Reports Financial and Operating Results for First Qu...
U.S. Energy Corp. Reports Financial and Operating Results for First Quarter 2024 HOUSTON, May 09, 2024 (GLOBE NEWSWIRE) -- U.S. Energy Corporation (NASDAQ: USEG, “U.S. Energy” or the “Company”), a growth-focused energy company engaged in operating a portfolio of high-quality producing oil and natural gas assets, today reported financial and operating results for the three months ended March 31, 2024. FIRST QUARTER 2024 HIGHLIGHTS Net daily production of 1,207 barrels of oil equivalent per day (“Boe/d”);Oil production of 68,599 barrels, or 62% of total production;Lease Operating Expense...
DBV Technologies to Participate in Upcoming Investor Conferences
DBV Technologies to Participate in Upcoming Investor Conferences Montrouge, France, May 9, 2024 DBV Technologies to Participate in Upcoming Investor Conferences DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company focused on treatment options for food allergies and other immunologic conditions with significant unmet medical need, today announced Daniel Tassé, Chief Executive Officer, will deliver a company presentation at two investor conferences in May. Citizens JMP Life Scie...
Sachem Capital Sets Dates for First Quarter 2024 Earnings Release and...
Sachem Capital Sets Dates for First Quarter 2024 Earnings Release and Conference Call BRANFORD, Conn., May 09, 2024 (GLOBE NEWSWIRE) -- Sachem Capital Corp. (NYSE American: SACH) (the “Company”) announced today that the Company will release its first quarter 2024 financial results before market open on Friday, May 10, 2024. A webcast and conference call to discuss the results will be held on Friday, May 10, 2024, at 8:00 a.m. Eastern Time. Webcast:A webcast of the conference call will be available on the Investors section of the Company’s website . To listen to the live broadcast, go to...
Participation de DBV Technologies aux conférences investisseurs en mai
Participation de DBV Technologies aux conférences investisseurs en mai Montrouge, France, le 9 mai Participation de DBV Technologies aux conférences investisseurs en mai DBV Technologies (Euronext : DBV - ISIN : FR0010417345 - Nasdaq Stock Market : DBVT), une société biopharmaceutique au stade clinique spécialisée dans les options de traitement des allergies alimentaires et d'autres conditions immunologiques présentant d'importants besoins médicaux non satisfaits, a annoncé aujourd'hui que Daniel Tassé, Directeur General de DBV, fera une présentation de l'entreprise lors de deu...
Tempest Reports First Quarter 2024 Financial Results and Provides Busi...
Tempest Reports First Quarter 2024 Financial Results and Provides Business Update Advancing TPST-1120 into a pivotal Phase 3 trial in first-line HCC and TPST-1495 into a Phase 2 in FAPReported new preclinical data for TPST-1120 in kidney cancer at the AACR Annual MeetingPublished positive data from the Phase 1 Trial of TPST-1120 in patients with advanced solid tumors in the Journal of Cancer Research CommunicationsPresented new data at the SITC 2024 Spring Scientific Meeting elucidating the mechanism of TPST-1120 and supporting its potential in multiple cancers BRISBANE, Calif., May 09...
Victory Capital Reports Strong First-Quarter Results
SAN ANTONIO, Texas--(BUSINESS WIRE)-- Victory Capital Holdings, Inc. (NASDAQ: VCTR) (“Victory Capital” or “the Company”) today reported financial results for the quarter ended March 31, 2024. “We achieved very strong results to start 2024,” said David Brown, Chairman and Chief Executive Officer. “During the first quarter, our long-term gross and net flows improved quarter-over-quarter and year-over-year, reaching their best levels in more than a year. This momentum accelerated toward the end of the quarter, with our long-term net flows turning positive in March. Additionally, we posted the h...
Genelux Corporation Reports First Quarter 2024 Financial Results and P...
Genelux Corporation Reports First Quarter 2024 Financial Results and Provides General Business Updates WESTLAKE VILLAGE, Calif., May 09, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced financial results for the first quarter of 2024 and provided general business updates. “Our pivotal Phase 3 registration trial of Olvi-Vec in platinum resistant/refractory ovarian cancer continues to enroll patients,” said , President, Chairman and CEO of Genelux. “Looking ahead, we are excited about advancing Olvi-Vec into additional cancer indica...
NHC Announces 3.4% Increase in Common Dividend
MURFREESBORO, Tenn.--(BUSINESS WIRE)-- (NYSE American: NHC), the nation’s oldest publicly traded long-term health care company, announced today that it will pay a quarterly dividend of 61 cents per common share to shareholders of record on June 28, 2024 and payable on August 1, 2024. This represents a 3.4% increase over last quarter’s regular common dividend. Forward-Looking Statements Statements in this press release that are not historical facts are forward-looking statements. NHC cautions investors that any forward-looking statements made involve risks and uncertainties and are not gua...
AMN Healthcare Announces First Quarter 2024 Results
AMN Healthcare Announces First Quarter 2024 Results Quarterly revenue of $821 million; GAAP EPS of $0.45 and adjusted EPS of $0.97 DALLAS, May 09, 2024 (GLOBE NEWSWIRE) -- AMN Healthcare Services, Inc. (NYSE: AMN), the leader and innovator in total talent solutions for healthcare organizations across the United States, today announced its first quarter 2024 financial results. Financial highlights are as follows: Dollars in millions, except per share amounts. Q1 2024% Change Q1 2023Revenue$820.9(27%) Gross profit$257.5(30%) Net income$17.3(79%) GAAP diluted EPS$0.45(78%) Adjusted dilute...
Jamf Announces Upcoming Conference Participation
Jamf Announces Upcoming Conference Participation MINNEAPOLIS, May 09, 2024 (GLOBE NEWSWIRE) -- Jamf (NASDAQ: JAMF), the standard in managing and securing Apple at work, announced today that members of its management team will present at the following investor conference: 19th Annual Needham Technology, Media & Consumer Conference on Wednesday, May 15, 2024, at 12:45pm Eastern Time Webcast of this event will be available on the investor relations section of the Company's website at . About JamfJamf’s purpose is to simplify work by helping organizations manage and secure an Apple experie...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.